News Focus
News Focus
icon url

williamssc

11/03/23 9:40 AM

#437957 RE: Investor2014 #437950

And then there's the data - "Anavex’s Phase 2b/3 Trial of Blarcamesine (ANAVEX®2-73) in Patients with Alzheimer’s Disease Shows Robust Clinical Efficacy and Slows Neurodegeneration"
icon url

kevindenver

11/03/23 9:57 AM

#437963 RE: Investor2014 #437950

It's $6 stock again... wheeee! We got this!...

Xena, Bas, and "G" are among my ignores... Ignore is such a great feature.